Literature DB >> 1083422

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

M J Bevan.   

Abstract

Cytotoxic effector T cells of F1 (BALB/c X BALB.B) (H-2d/b) mice immunized against the minor histocompatibility differences of C57BL/10 (H-2b) can lyse targets from C57BL/10, but cannot lyse B10.D2 (H-2d) targets. Despite this lack of cross-reaction in the cytotoxic assay, C57BL/10 cells do prime F1 (BALB/c X BALB.B) mice for a secondary cytotoxic response to B10.D2. C57BL/10-primed, B10.D2-boosted cytotoxic cells lyse B10.D2 targets but not C57BL/10 targets. DBA/2 (H-2d) spleen cells or thymocytes prime F1 mice for a secondary response to DBA/2, B10.D2, and C57BL/10 cells, but DBA/2 mastocytes, P815, do not prime for a response to C57BL/10. Whether H-2 congenic lymphoid cells express minor histocompatibility determinants which cross-react at the cytotoxic T-cell level or the helper T-cell level is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083422      PMCID: PMC2190184          DOI: 10.1084/jem.143.5.1283

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Absence of gene interaction in mouse hybrids, revealed by studies of immunological tolerance and homotransplantation.

Authors:  C MARTINEZ; F SHAPIRO; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

2.  A new method of typing inbred strains of mice for histocompatibility antigens.

Authors:  G D SNELL; N WHEELER; M AARON
Journal:  Transplant Bull       Date:  1957-01

3.  The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products.

Authors:  D H Katz; B Benacerraf
Journal:  Transplant Rev       Date:  1975

4.  Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier.

Authors:  M J Bevan
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

5.  Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex.

Authors:  R V Blanden; P C Doherty; M B Dunlop; I D Gardner; R M Zinkernagel; C S David
Journal:  Nature       Date:  1975-03-20       Impact factor: 49.962

Review 6.  Genetics and immunology of sex-linked antigens.

Authors:  D L Gasser; W K Silvers
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

7.  Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.

Authors:  U Koszinowski; R Thomssen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

8.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

  10 in total
  240 in total

1.  Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.

Authors:  V B Pinto; S Prasad; J Yewdell; J Bennink; S H Hughes
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Regulatory function of in vivo anergized CD4(+) T cells.

Authors:  K Jooss; B Gjata; O Danos; H von Boehmer; A Sarukhan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques.

Authors:  Francois Villinger; Ann E Mayne; Pavel Bostik; Kazuyasu Mori; Peter E Jensen; Rafi Ahmed; Aftab A Ansari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Defective cross-presentation of viral antigens in GILT-free mice.

Authors:  Reshma Singh; Peter Cresswell
Journal:  Science       Date:  2010-06-11       Impact factor: 47.728

5.  Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.

Authors:  Megan K L MacLeod; Amy S McKee; Alexandria David; Jieru Wang; Robert Mason; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 6.  Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies?

Authors:  Nicole Selenko; Otto Majdic; Ulrich Jäger; Christian Sillaber; Johannes Stöckl; Walter Knapp
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

7.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

8.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 9.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.